Healthcare News

Highlights for Fiscal 2016 First Half:  Strategic Objective Achievements Announcement of transformative merger agreement with Aspen Park Pharmaceutical, Inc.Completion of FC2 consumer market...

MORRISTOWN, N.J., April 28, 2016 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that it will release financial results for...

CAMBRIDGE, Mass., April 28, 2016 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) is scheduled to present at the Bloom Burton Healthcare Investor Conference on Monday, May 2nd at 1:30 PM...

LYON, France, April 28, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that The Brazilian Health Surveillance Agency (Anvisa) has...

CAMBRIDGE, Mass., April 28, 2016 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today...

SAN FRANCISCO, April 28, 2016 (GLOBE NEWSWIRE) -- BioQ Pharma Incorporated, a specialty pharmaceutical company, today announced the expansion of its license and supply agreement with Sandoz, a...

EXTON, Pa., April 28, 2016 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), an autologous cell and gene therapy company focused on developing transformational therapies for diseases...

SOUTH SAN FRANCISCO, Calif., April 28, 2016 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. (Nasdaq:PTLA) announced today that it will host a webcast and conference call to discuss the Company’s...

WIXOM, Mich., April 28, 2016 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney...

CAMBRIDGE, Mass., April 28, 2016 (GLOBE NEWSWIRE) -- Dimension Therapeutics, Inc. (NASDAQ:DMTX), a biopharmaceutical company advancing novel, adeno-associated virus (AAV) gene therapies targeting...